- Home
- IVVD vs MHH Comparison
IVVD vs MHH Comparison
Compare IVVD & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- MHH
- Stock Information
- Founded
- IVVD 2020
- MHH 1986
- Country
- IVVD United States
- MHH United States
- Employees
- IVVD N/A
- MHH N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- MHH Professional Services
- Sector
- IVVD Health Care
- MHH Consumer Discretionary
- Exchange
- IVVD Nasdaq
- MHH Nasdaq
- Market Cap
- IVVD 69.0M
- MHH 78.2M
- IPO Year
- IVVD 2021
- MHH N/A
- Fundamental
- Price
- IVVD $0.74
- MHH $7.49
- Analyst Decision
- IVVD Strong Buy
- MHH
- Analyst Count
- IVVD 3
- MHH 0
- Target Price
- IVVD $5.85
- MHH N/A
- AVG Volume (30 Days)
- IVVD 1.3M
- MHH 22.4K
- Earning Date
- IVVD 08-13-2025
- MHH 08-06-2025
- Dividend Yield
- IVVD N/A
- MHH N/A
- EPS Growth
- IVVD N/A
- MHH N/A
- EPS
- IVVD N/A
- MHH 0.17
- Revenue
- IVVD $36,688,000.00
- MHH $200,437,000.00
- Revenue This Year
- IVVD $446.60
- MHH $1.22
- Revenue Next Year
- IVVD $112.63
- MHH $5.41
- P/E Ratio
- IVVD N/A
- MHH $42.67
- Revenue Growth
- IVVD N/A
- MHH 3.93
- 52 Week Low
- IVVD $0.35
- MHH $6.20
- 52 Week High
- IVVD $2.74
- MHH $16.00
- Technical
- Relative Strength Index (RSI)
- IVVD 48.03
- MHH 57.56
- Support Level
- IVVD $0.70
- MHH $6.86
- Resistance Level
- IVVD $0.77
- MHH $8.15
- Average True Range (ATR)
- IVVD 0.05
- MHH 0.62
- MACD
- IVVD -0.00
- MHH 0.10
- Stochastic Oscillator
- IVVD 45.94
- MHH 59.01
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.